Helicobacter pylori Eradication: Why Recurrence Risk Should Not Dictate Treatment Decisions

Xinglan Chen, Yuanyuan Wang, Yeze Dong, Jinxia Yang, Baoyuan Xie, Dekui Zhang · 2025

Read Helicobacter pylori Eradication: Why Recurrence Risk Should Not Dictate Treatment Decisions by Xinglan Chen, Yuanyuan Wang, Yeze Dong, Jinxia Yang, Baoyuan Xie, Dekui Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751280.txt.

Description

A stomach germ that drives ulcers and cancer should be wiped out in nearly all patients, yet fears that it often returns have made some doctors hesitate. Xinglan Chen and co-authors review the return-rate evidence in this 2025 paper and argue it should not drive treatment choices. Guidelines already urge treatment for all eligible patients.

The review searched major databases and sorted true relapse from new infection caught again from others. Many early reports of high returns mixed the two or used weak tests. When strict methods are used, true returns are far less common. Withholding a cancer-preventing treatment over an inflated fear does real harm. The paper gives clinicians a firmer footing for urging patients to complete the drug course.

Catalog record

CREATORXinglan Chen, Yuanyuan Wang, Yeze Dong, Jinxia Yang, Baoyuan Xie, Dekui Zhang
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12751280

Browse the full library · About the Tower of Babel